CD19 and plasma cell myeloma: In all patients that contained CD19high and CD19low myeloma cells, we found that CD19-expressing myeloma cells were eliminated and only CD19-negative myeloma cells were present after the treatment (Fig. 3 and Supplementary Fig. 4).